van Capelle Jan-Willem, de Haan Tjard, El Sayed Wayed, Azmy Amir
Department of Urology, Isala Klinieken, Sophia, Zwolle, the Netherlands.
BJU Int. 2004 Dec;94(9):1348-51. doi: 10.1111/j.1464-410X.2004.05172.x.
To determine the long-term efficacy of endoscopically implanting polydimethylsiloxane (PDS, Macroplastique, Uroplasty BV, Geleen, the Netherlands) for treating vesico-ureteric reflux (VUR) in children.
We retrospectively reviewed the records of 195 children treated with PDS over the past 10 years in two European centres (Netherlands and UK) and conducted follow-up investigations where deemed necessary. In the Dutch centre patients were treated according to a prospective approved study protocol.
Of the 195 treated children, 155 had a successful outcome; in all, 311 refluxing renal units were treated, with an overall success rate of 82.3% in a mixed group of patients with unilateral or bilateral VUR and duplex systems.
The long-term data from these two independent centres confirms the viability of PDS and the technique for treating VUR in children. We conclude that the material is safe and effective and can be used in VUR grades II-V. Treating patients with grade I VUR is recommended in those cases where there is no spontaneous resolution and 'breakthrough' infections.
确定内镜下植入聚二甲基硅氧烷(PDS,Macroplastique,Uroplasty BV,荷兰海尔伦)治疗儿童膀胱输尿管反流(VUR)的长期疗效。
我们回顾性分析了过去10年在两个欧洲中心(荷兰和英国)接受PDS治疗的195例儿童的记录,并在必要时进行了随访调查。在荷兰中心,患者按照一项前瞻性批准的研究方案进行治疗。
在195例接受治疗的儿童中,155例取得了成功的结果;总共治疗了311个反流性肾单位,在单侧或双侧VUR及重复肾系统的混合患者组中,总体成功率为82.3%。
来自这两个独立中心的长期数据证实了PDS及该技术治疗儿童VUR的可行性。我们得出结论,该材料安全有效,可用于II - V级VUR。对于I级VUR患者,建议在无自然缓解及“突破性”感染的情况下进行治疗。